Fundraising FoxCanaan Partners — 2026 Investments
15 investments dated 2026 · listed companies and verified rows first · show all
Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.
BiotechNew Haven, US
Barbara Fox(Executive Officer, Director)inNicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)inRanjit Bindra(Director)in
BoardMatthew Cohen(Director)in
Board seatColleen Cuffaro· per SEC Form D
Co-investorsConnecticut InnovationsHighCape CapitalOUP (Osage University Partners)
Portal Space Systems develops advanced spacecraft, including its flagship Supernova vehicle, designed for high delta-v maneuverability and multi-orbit operations in cislunar space.
Deep TechHardwareSpace TechWashington, US
Jeffery Thornburg(Executive Officer, Director, Promoter)Ian Vorbach(Founder)inPrashaanth Ravindran(Founder)inJeff Thornburg(Founder)
Board seatRayfe Gaspar-Asaoka· per SEC Form D
Co-investorsAlleyCorpBooz Allen VenturesFUSEGeodesic CapitalIceNineTFX Capital+7 more
Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.
BiotechMedical DevicesDedham, US
Thurein Htoo(Executive Officer, Director)inFred Guerard(President & Chief Executive Officer)inBarbara Wirostko(Executive Officer)
BoardRonald M. Hunt(Director)Andrew Danielson(Director)
Board seatWende Hutton· per SEC Form D
Co-investorsabrdn plcCorrelation VenturesMayo Clinic VenturesNew Leaf Venture Partners
Solstice Oncology is a clinical-stage immuno-oncology company developing porustobart, a second-generation engineered CTLA-4 antibody given with anti–PD-1 therapy in the neoadjuvant (pre-surgery) setting to treat early-stage cancers.
BiotechHealthtechBoston, US
David Feltquate(Chief Medical Officer)inMaiken Keson-Brookes(Chief Operating Officer & General Counsel)CAROLINE LOEW(Executive Officer, Director, Promoter)Caroline J. Loew(President & Chief Executive Officer)
BoardANDREW LEVIN(Director)
Board seatJulie Grant· per SEC Form D
Co-investorsRA CapitalForbion
HeyMilo provides AI-powered recruiting tools for hiring teams, including adaptive voice, video, phone, and SMS interviews, resume screening, cheat/impersonation detection, and analytics.
AI & Machine LearningHR TechSaaSNew York City, US
Ramie R(Founder)Sabashan Ragavan Ramie Raufdeen(Founder)
Co-investorsAlumni VenturesCategory VenturesEntrepreneurs Roundtable Accelerator (ERA)Remarkable VenturesTwo Sigma Ventures
Mate Academy offers an online Product Analyst course designed to teach data analysis, SQL, Python, and product metrics to beginners transitioning into the tech industry.
Data & InfrastructureEdTechSaaSKyiv, UA
Roman Apostol(Founder)inAnna Apostol(Founder)inMax Lysak(Founder)inMaksym Lysak(Founder)
Co-investorsFlyer One VenturesInsight PartnersM12 (Microsoft's Venture Fund)Team8u.ventures
Oncology Ventures is a cancer-focused venture capital fund that invests in healthcare technology startups related to oncology care.
AI & Machine LearningBiotechDigital HealthHealthtech
Ben Freeberg(Founder, Managing Partner)inJay Freeberg(Chief Financial Officer)
Co-investorsSandwich CapitalAlleyCorpConcord Health PartnersCVS Health VenturesForbionForesite Capital+5 more
OpenArt Worlds is an AI tool that turns a single image or text prompt into a navigable 3D environment, letting users place characters, objects, and lighting and control camera angles.
AI & Machine LearningConsumerCreator EconomyMedia & EntertainmentSan Francisco, US
Coco Mao(Founder)inJohn Qiao(Founder)
Co-investorsBasis Set VenturesCapitalOvenDCM VenturesFELIX CAPITALSouth QuadCostanoa Ventures
Replicant builds AI Agents that handle customer service conversations across voice, chat, and SMS, using a company's existing conversation data to resolve specific workflows.
AI & Machine LearningEnterprise SoftwareSaaSSales Tech
Gadi Shamia(Founder)inBenjamin Gleitzman(Founder)inBen Gleitzman(Founder)Jeremy Powers(Founder)Josh Lerman(Founder)
Co-investorsAlumni VenturesAtomicBloomberg BetaKhosla VenturesNorwest Venture PartnersOmega Venture Partners+7 more
SageOx builds a team-memory platform that captures decisions, discussions, and AI agent sessions and makes that context available to both people and AI assistants.
AI & Machine LearningDeveloper ToolsFuture of WorkSaaSSeattle, US
Ajit Banerjee(Founder)inMilkana Brace(Founder)inRyan Snodgrass(Founder)in
Co-investorsA.Capital VenturesFounders' Co-opPioneer Square Labs
Smack builds domain-specific AI models for military decision-making.
AI & Machine LearningDeep TechDefense TechBoston, US
Andy Markoff(Founder & CEO)inClint Alanis(COO & Co-Founder)inDan Gould(Head of Strategy & Co-Founder)Giuseppe Stuto(Executive Officer, Director)Frank Iudiciani(Executive Officer, Director)
Co-investorsCostanoa VenturesFelicis VenturesFulcrum VentureGeodesic CapitalNomi Capital Defense Fund IPalumni VC+8 more
Telit designs and manufactures telecommunications terminal equipment and M2M (machine-to-machine) modules for industrial and IoT applications.
AI & Machine LearningEnterprise SoftwareHardwareIoTBoca Raton, US
Co-investors83NorthIn-Q-TelYL VenturesZeev Ventures
Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies.
BiotechHealthtechMedical Devices
Co-investorsWestlake Village BioPartners
Workhelix provides enterprise leaders with real-time visibility into their AI adoption, quantifying time saved, mapping AI opportunities, and linking usage to business outcomes.
AI & Machine LearningEnterprise SoftwareSaaSBeaverton, US
Erik Brynjolfsson(Co-Founder & Co-Chairman of the Board)inAndrew McAfee(Co-Founder & Co-Chairman of the Board)inDaniel Rock(Founder)inShaun Johnson(Director)inJames Milin(Co-Founder and CEO)in
Co-investorsAI FundAIX VenturesBloomberg BetaFOW PartnersAccenture VenturesAdverb Ventures+17 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.